Legend Biotech (LEGN) Return on Assets (2020 - 2025)

Legend Biotech (LEGN) has reported Return on Assets for 6 consecutive years, with 0.0% the latest figure, recorded in Q4 2025.

• Return on Assets for Q4 2025 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Assets was 0.0% for Q4 2025 at Legend Biotech, down from 0.0% in the prior quarter.
• Over five years, Return on Assets peaked at 0.0% in Q1 2023 and troughed at 16.58% in Q1 2021.
• Average Return on Assets over 5 years is 0.98%, with a median of 0.0% recorded in 2024.
• Year-over-year, Return on Assets jumped 1658 bps in 2022 and changed 0 bps in 2023.
• Over 5 years, Return on Assets stood at 0.0% in 2021, then increased by 3 bps to 0.0% in 2022, then climbed by 23 bps to 0.0% in 2023, then soared by 71 bps to 0.0% in 2024, then tumbled by 90 bps to 0.0% in 2025.
• Per Business Quant data, the three most recent Return on Assets figures were 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.